Page last updated: 2024-11-07

etiocholanolone and Diabetic Cardiomyopathies

etiocholanolone has been researched along with Diabetic Cardiomyopathies in 1 studies

Etiocholanolone: The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.
3alpha-hydroxy-5beta-androstan-17-one : An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Torre, E1
Arici, M1
Lodrini, AM1
Ferrandi, M1
Barassi, P1
Hsu, SC1
Chang, GJ1
Boz, E1
Sala, E1
Vagni, S1
Altomare, C1
Mostacciuolo, G1
Bussadori, C1
Ferrari, P1
Bianchi, G1
Rocchetti, M1

Other Studies

1 other study available for etiocholanolone and Diabetic Cardiomyopathies

ArticleYear
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
    Cardiovascular research, 2022, 03-16, Volume: 118, Issue:4

    Topics: Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Etiocholanolone; Rats;

2022